MOTS-c: Mitochondrial-Derived Peptide Research

Mitochondrial-Derived Peptides: A New Research Frontier

MOTS-c (Mitochondrial Open Reading Frame of the Twelve S rRNA type-c) is a 16-amino acid peptide encoded within the mitochondrial genome. Its discovery in 2015 established a new category of bioactive peptides — mitochondrial-derived peptides (MDPs) — that are encoded by short open reading frames within mitochondrial ribosomal RNA genes rather than the nuclear genome.

This mitochondrial origin distinguishes MOTS-c from nearly all other research peptides, which are derived from nuclear-encoded genes. The existence of functional peptides encoded within mitochondrial rRNA sequences has expanded understanding of mitochondrial biology and opened new areas of preclinical investigation into mitochondrial-nuclear communication and cellular energy regulation signaling.

AMPK Pathway Activation Research

In preclinical cellular models, MOTS-c has been documented to activate AMP-activated protein kinase (AMPK), a central energy-sensing kinase that regulates metabolic homeostasis through multiple downstream signaling cascades. AMPK activation by MOTS-c is studied using phosphorylation-specific antibodies, kinase activity assays, and downstream target analysis in muscle cell lines and hepatocyte models.

The AMPK activation mechanism of MOTS-c is investigated through its interaction with the folate-methionine cycle, where MOTS-c modulates one-carbon metabolism and de novo purine biosynthesis. This metabolic pathway interaction leads to accumulation of the AMPK-activating intermediate AICAR (5-aminoimidazole-4-carboxamide ribonucleotide), providing a documented mechanistic link between MOTS-c and AMPK pathway engagement.

Nuclear Translocation & Gene Regulation

Research has demonstrated that MOTS-c can translocate from the cytoplasm to the nucleus under metabolic stress conditions, where it interacts with nuclear DNA and modulates gene expression. This retrograde mitochondrial-to-nuclear signaling represents a novel communication pathway between mitochondria and the nuclear genome.

Nuclear MOTS-c has been shown to bind to antioxidant response elements (AREs) in nuclear DNA and regulate the expression of genes involved in cellular stress response pathways. Chromatin immunoprecipitation (ChIP) assays and transcriptomic analyses in laboratory settings characterize the genomic binding sites and gene regulatory effects of nuclear MOTS-c under varying experimental conditions.

Cellular Energy Metabolism Research

MOTS-c is studied in preclinical models examining cellular energy metabolism, glucose uptake signaling, and mitochondrial function. Metabolomic profiling of MOTS-c-treated cells reveals changes in nucleotide metabolism, folate cycle intermediates, and downstream metabolic pathway flux that collectively influence cellular energy balance.

Research laboratories use oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) measurements, mitochondrial membrane potential assays, and ATP quantification to characterize MOTS-c's effects on mitochondrial function and cellular bioenergetics. These standardized metabolic assays provide quantitative data on MOTS-c's influence on cellular energy regulation pathways.

Structural Characterization & Stability

MOTS-c is a 16-amino acid peptide (sequence: MRWQEMGYIFYPRKLR) with a molecular weight of approximately 2174 Da. Analytical characterization through reverse-phase HPLC, ESI-MS, and amino acid analysis confirms identity, purity, and compositional accuracy for research-grade material. Stability studies evaluate degradation under varying temperature, pH, and storage conditions to establish optimal handling protocols. At Instant Peptides, MOTS-c undergoes seven rounds of independent third-party analytical testing with full COA documentation available through our Batch Verification Tool.